| scholarly article | Q13442814 |
| P2093 | author name string | J J Ferguson | |
| J A Dieck | |||
| P2860 | cites work | Fibrinolytic mechanisms and the development of thrombolytic therapy | Q79475541 |
| THE PHYSIOLOGY OF MASSIVE PULMONARY EMBOLISM: AN EXPERIMENTAL STUDY OF THE CHANGES PRODUCED BY OBSTRUCTION TO THE FLOW OF BLOOD THROUGH THE PULMONARY ARTERY AND ITS LOBAR BRANCHES | Q24542628 | ||
| The hypercoagulable states | Q33447844 | ||
| Cardiopulmonary function in patients with pulmonary hypertension | Q33603222 | ||
| Natural history of pulmonary embolism | Q33971685 | ||
| Modification by beta-adrenergic blockade of the circulatory respones to acute hypoxia in man. | Q34266464 | ||
| Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data | Q36644709 | ||
| Long-term prognosis of treated acute massive pulmonary embolism | Q36804254 | ||
| Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy | Q39594096 | ||
| Pulmonary hypertension from chronic pulmonary thromboembolism | Q39628557 | ||
| Preventive and therapeutic approach to venous thromboembolic disease and pulmonary embolism--can death from pulmonary embolism be prevented? | Q39749124 | ||
| Angiography, scanning, and hemodynamics in pulmonary embolism: critical review and correlations | Q39924344 | ||
| Hemodynamic and ventricular responses to pulmonary embolism | Q39946960 | ||
| The Rate of Resolution of Pulmonary Embolism and its Effects on Early Survival | Q39993203 | ||
| A Reconsideration of the Origins of Pulmonary Hypertension | Q40019584 | ||
| Gas exchange alterations following pulmonary thromboembolism. | Q40214314 | ||
| Alterations in gas exchange following pulmonary thromboembolism | Q40263980 | ||
| Hypoxemia in pulmonary embolism, a clinical study | Q40324465 | ||
| A Prospective Study of Streptokinase and Heparin in the Treatment of Deep Vein Thrombosis | Q40906352 | ||
| A Controlled Clinical Trial of Streptokinase and Heparin in the Treatment of Major Pulmonary Embolism | Q40906357 | ||
| A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: An interim report of a prospective trial | Q41129735 | ||
| DISTURBANCES IN THE CIRCULATION IN PATIENTS WITH COR PULMONALE | Q41960806 | ||
| Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 cases | Q43614397 | ||
| Thrombolytic treatment with recombinant tissue-type plasminogen activator in a patient with massive pulmonary embolism | Q43629666 | ||
| The phase II urokinase-streptokinase pulmonary embolism trial: a national cooperative study | Q43777474 | ||
| Secundum atrial septal defect with severe pulmonary hypertension. Open lung biopsy diagnosis of operative indication | Q43827523 | ||
| Treatment of pulmonary embolism with full-dose heparin, streptokinase or embolectomy--results and indications | Q44171892 | ||
| Comparison of heparin and streptokinase in the treatment of venous thrombosis | Q44658427 | ||
| Pulmonary embolism: epidemiology and pathology | Q44770595 | ||
| Gas exchange after pulmonary thromboemoblization in dogs | Q45060260 | ||
| The pathologic physiology of pulmonary embolism. A physiologic discussion of the vascular reactions following pulmonary arterial obstruction by emboli of varying size | Q47432852 | ||
| Treatment of Deep Vein Thrombosis. A Trial of Heparin, Streptokinase, and Arvin | Q49169856 | ||
| Determinants of hypoxemia during the acute phase of pulmonary embolism in humans | Q49212178 | ||
| The mechanisms of abnormal gas exchange in acute massive pulmonary embolism. | Q52433281 | ||
| Regional and transmural myocardial blood flow studies in experimental pulmonary embolism. | Q53783847 | ||
| Venoarterial shunting in obstructive pulmonary disease. | Q53805971 | ||
| Mechanism of arterial hypoxemia following pulmonary thromboembolism in dogs | Q54624738 | ||
| The urokinase-streptokinase pulmonary embolism trial (phase II) results. | Q54632732 | ||
| Resolution rate of acute pulmonary embolism in man. | Q54687624 | ||
| Hemodynamic monitoring in acute pulmonary embolism | Q67454811 | ||
| Streptokinase and urokinase in the treatment of pulmonary thromboemboli; from a national cooperative study | Q67488704 | ||
| Clinical primary pulmonary hypertension: three pathologic types | Q67693557 | ||
| Treatment of massive acute pulmonary embolism. The use of low doses of intrapulmonary arterial streptokinase combined with full doses of systemic heparin | Q68256443 | ||
| Treatment of pulmonary embolism | Q68955795 | ||
| Pulmonary angiography in severe chronic pulmonary hypertension | Q69263037 | ||
| Comparison by Controlled Clinical Trial of Streptokinase and Heparin in Treatment of Life-threatening Pulmonary Embolism | Q69335295 | ||
| Persistent post-embolic pulmonary hypertension | Q69385872 | ||
| Quantitative two-dimensional echocardiography in massive pulmonary embolism: emphasis on ventricular interdependence and leftward septal displacement | Q69448549 | ||
| Late prognosis of acute pulmonary embolism | Q69533795 | ||
| [Does thrombolytic treatment modify the prognosis of pulmonary embolism?] | Q69641509 | ||
| Pulmonary embolism from a venous thrombus located below the knee | Q69743010 | ||
| Massive pulmonary embolism: embolectomy or thrombolysis? | Q69787847 | ||
| Acute pulmonary embolism treated with tissue plasminogen activator | Q69887713 | ||
| Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator | Q70040001 | ||
| Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction | Q70051806 | ||
| Cerebrovascular complications of streptokinase infusion | Q70062664 | ||
| [Hemodynamic course during fibrinolysis in severe pulmonary embolism] | Q70301230 | ||
| Intravenous and intrapulmonary recombinant tissue-type plasminogen activator in the treatment of acute massive pulmonary embolism | Q70373273 | ||
| The natural history of pulmonary embolism | Q70642742 | ||
| The clinical profile of unresolved pulmonary embolism | Q71098963 | ||
| Respiratory function in pulmonary thromboembolic disease | Q71267772 | ||
| Effect of thrombolytic therapy on pulmonary-capillary blood volume in patients with pulmonary embolism | Q71310468 | ||
| Restoration of Blood Flow After Pulmonary Embolism | Q71411624 | ||
| Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan | Q71757661 | ||
| Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary Embolism | Q71786257 | ||
| Serum sickness following streptokinase therapy | Q72101311 | ||
| Factors Influencing the Restoration of Blood Flow Following Pulmonary Embolization as Determined by Angiography and Scanning | Q72219892 | ||
| Recovery of Pulmonary Arterial Blood Flow in Patients with Pulmonary Embolism | Q72221549 | ||
| Urokinase therapy in clinical pulmonary embolism. A new thrombolytic agent | Q72309504 | ||
| Comparative circulatory responses to systemic hypoxia in man and in unanesthetized dog | Q72338076 | ||
| Cardiovascular responses to hypoxia and varying PCO2 in the awake dog | Q72415847 | ||
| Platelet Adherence to Thromboemboli in Relation to the Pathogenesis and Treatment of Pulmonary Embolism | Q72773836 | ||
| Cardiopulmonary consequences of acute pulmonary embolic disease | Q72948695 | ||
| Reflex and direct cardiopulmonary effects of 5-OH-tryptamine (serotonin); their possible role in pulmonary embolism and coronary thrombosis | Q73193900 | ||
| Unrecognized emboli to the lungs with subsequent cor pulmonale | Q73340932 | ||
| Mechanical vs. reflex effects of diffuse pulmonary embolism in anesthetized dogs | Q74016231 | ||
| Serotonin (5-hydroxytryptamine) and pulmonary thromboembolism | Q78899568 | ||
| The fate and late effects of non-fatal pulmonary emboli | Q79456259 | ||
| P433 | issue | 1 | |
| P921 | main subject | thrombolysis | Q1931577 |
| P304 | page(s) | 19-26 | |
| P577 | publication date | 1989-01-01 | |
| P1433 | published in | Texas Heart Institute Journal | Q26841976 |
| P1476 | title | Indications for thrombolytic therapy in acute pulmonary embolism | |
| P478 | volume | 16 |
| Q37068195 | Timely embolectomy in acute massive pulmonary embolism prevents catastrophe: An experience from two cases |
| Q47133264 | Use of Tachycardia in Patients With Submassive Pulmonary Emboli to Risk Stratify for Early Initiation of Thrombolytic Therapy: A Case Series Comparing Early Versus Late Thrombolytic Initiation |
Search more.